Cargando…
Characterization of 405B8H3(D‐E), a newly engineered high affinity chimeric LAG‐3 antibody with potent antitumor activity
Lymphocyte activation gene‐3 (LAG‐3) is a type I transmembrane protein with structural similarities to CD4. Overexpression of LAG‐3 enables cancer cells to escape immune surveillance, while its blockade reinvigorates exhausted T cells and strengthens anti‐infection immunity. Blockade of LAG‐3 may ha...
Autores principales: | Lan, Xiaoxuan, Yang, Teddy Tat Chi, Wang, Yinghui, Qu, Baoyuan, Rong, Shaofeng, Song, Ningning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315732/ https://www.ncbi.nlm.nih.gov/pubmed/37302810 http://dx.doi.org/10.1002/2211-5463.13648 |
Ejemplares similares
-
Zip Nucleic Acids: new high affinity oligonucleotides as potent primers for PCR and reverse transcription
por: Moreau, Valérie, et al.
Publicado: (2009) -
GUNC: detection of chimerism and contamination in prokaryotic genomes
por: Orakov, Askarbek, et al.
Publicado: (2021) -
Enhanced antitumor immunity through sequential targeting of PI3Kδ and LAG3
por: Lauder, Sarah Nicol, et al.
Publicado: (2020) -
Lag times in the publication of network meta-analyses: a survey
por: Tonin, Fernanda S, et al.
Publicado: (2021) -
Identification of LAG3 high affinity aptamers by HT-SELEX and Conserved Motif Accumulation (CMA)
por: Soldevilla, Mario Martínez, et al.
Publicado: (2017)